Literature DB >> 19246514

Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1alpha.

Sandra M Malakauskas1, Wissam M Kourany, Xiao Yin Zhang, Danhong Lu, Robert D Stevens, Timothy R Koves, Hans E Hohmeier, Deborah M Muoio, Christopher B Newgard, Thu H Le.   

Abstract

Collectrin is a downstream target of the transcription factor hepatocyte nuclear factor-1alpha (HNF-1alpha), which is mutated in maturity-onset diabetes of the young subtype 3 (MODY3). Evidence from transgenic mouse models with collectrin overexpression in pancreatic islets suggests divergent roles for collectrin in influencing beta-cell mass and insulin exocytosis. To clarify the function of collectrin in the pancreas, we used a mouse line with targeted deletion of the gene. We examined pancreas morphology, glucose homeostasis by ip glucose tolerance testing (IPGTT) and insulin tolerance testing (IPITT), and pancreas function by in vivo acute-phase insulin response determination and glucose-stimulated insulin secretion from isolated islets. We find no difference in either pancreas morphology or function between wild-type and collectrin-deficient animals (Tmem27(-/y)). However, we note that by 6 months of age, Tmem27(-/y) mice exhibit increased insulin sensitivity by IPITT and decreased adiposity by dual-energy x-ray absorptiometry scanning compared with wild-type. We have previously reported that Tmem27(-/y) mice exhibit profound aminoaciduria due to failed renal recovery. We now demonstrate that Tmem27(-/y) animals also display inappropriate excretion of some short-chain acylcarnitines derived from amino acid and fatty acid oxidation. We provide further evidence for compensatory up-regulation of oxidative metabolism in Tmem27(-/y) mice, along with enhanced protein turnover associated with preserved lean mass even out to 1.5 yr of age. Our studies suggest that collectrin-deficient mice activate a number of adaptive mechanisms to defend energy homeostasis in the setting of ongoing nutrient losses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246514      PMCID: PMC2691681          DOI: 10.1210/me.2008-0274

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  43 in total

1.  Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism.

Authors:  D S Millington; N Kodo; D L Norwood; C R Roe
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  Carnitine esters in metabolic disease.

Authors:  H Böhles; A Evangeliou; K Bervoets; I Eckert; A Sewell
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

3.  Regulation of insulin secretion from novel engineered insulinoma cell lines.

Authors:  H E Hohmeier; H BeltrandelRio; S A Clark; R Henkel-Rieger; K Normington; C B Newgard
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

Review 4.  Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.

Authors:  A T Hattersley
Journal:  Diabet Med       Date:  1998-01       Impact factor: 4.359

5.  Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

Authors:  K Yamagata; N Oda; P J Kaisaki; S Menzel; H Furuta; M Vaxillaire; L Southam; R D Cox; G M Lathrop; V V Boriraj; X Chen; N J Cox; Y Oda; H Yano; M M Le Beau; S Yamada; H Nishigori; J Takeda; S S Fajans; A T Hattersley; N Iwasaki; T Hansen; O Pedersen; K S Polonsky; G I Bell
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

6.  Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.

Authors:  M Pontoglio; J Barra; M Hadchouel; A Doyen; C Kress; J P Bach; C Babinet; M Yaniv
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

7.  Evidence for intermediate channeling in mitochondrial beta-oxidation.

Authors:  M A Nada; W J Rhead; H Sprecher; H Schulz; C R Roe
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

8.  Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney.

Authors:  B M Hokland; J Bremer
Journal:  Biochim Biophys Acta       Date:  1986-04-29

9.  Hypoxia-induced amphiphiles inhibit renal Na+, K(+)-ATPase.

Authors:  M Schonefeld; S Noble; A M Bertorello; L J Mandel; M H Creer; D Portilla
Journal:  Kidney Int       Date:  1996-05       Impact factor: 10.612

10.  Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in developing mouse.

Authors:  M Blumenfeld; M Maury; T Chouard; M Yaniv; H Condamine
Journal:  Development       Date:  1991-10       Impact factor: 6.868

View more
  14 in total

1.  Pancreatic islet and progenitor cell surface markers with cell sorting potential.

Authors:  J Hald; T Galbo; C Rescan; L Radzikowski; A E Sprinkel; H Heimberg; J Ahnfelt-Rønne; J Jensen; R Scharfmann; G Gradwohl; K H Kaestner; C Stoeckert; J N Jensen; O D Madsen
Journal:  Diabetologia       Date:  2011-09-23       Impact factor: 10.122

2.  Renal Collectrin Protects against Salt-Sensitive Hypertension and Is Downregulated by Angiotensin II.

Authors:  Pei-Lun Chu; Joseph C Gigliotti; Sylvia Cechova; Gabor Bodonyi-Kovacs; Fang Chan; Donna Lee Ralph; Nancy Howell; Kambiz Kalantari; Alexander L Klibanov; Robert M Carey; Alicia A McDonough; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2017-01-06       Impact factor: 10.121

3.  Identification of novel inhibitors of the amino acid transporter B0 AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes.

Authors:  Qi Cheng; Nishank Shah; Angelika Bröer; Stephen Fairweather; Yang Jiang; Dieter Schmoll; Ben Corry; Stefan Bröer
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

4.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

Review 5.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Classical Renin-Angiotensin system in kidney physiology.

Authors:  Matthew A Sparks; Steven D Crowley; Susan B Gurley; Maria Mirotsou; Thomas M Coffman
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

7.  Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion.

Authors:  Emma Burgos-Ramos; Sandra Canelles; Arancha Perianes-Cachero; Eduardo Arilla-Ferreiro; Jesús Argente; Vicente Barrios
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  Angiotensin-converting enzyme 2: the first decade.

Authors:  Nicola E Clarke; Anthony J Turner
Journal:  Int J Hypertens       Date:  2011-11-10       Impact factor: 2.420

9.  Mice lacking neutral amino acid transporter B(0)AT1 (Slc6a19) have elevated levels of FGF21 and GLP-1 and improved glycaemic control.

Authors:  Yang Jiang; Adam J Rose; Tjeerd P Sijmonsma; Angelika Bröer; Anja Pfenninger; Stephan Herzig; Dieter Schmoll; Stefan Bröer
Journal:  Mol Metab       Date:  2015-02-16       Impact factor: 7.422

10.  Identification of known and novel pancreas genes expressed downstream of Nkx2.2 during development.

Authors:  Keith R Anderson; Peter White; Klaus H Kaestner; Lori Sussel
Journal:  BMC Dev Biol       Date:  2009-12-10       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.